Chronic lymphocytic leukemia (CLL) cells display features consistent with a defect in apoptosis and exhibit prolonged survival in vivo. Survival of these malignant cells is influenced by interactions with non-leukemic cells located in permissive niches in lymphoid organs. Leukemic cells subvert the normal architecture of the lymphoid organs, recruiting stromal cells, dendritic cells and T lymphocytes, all reported as playing active roles in the survival and proliferation of CLL. The same survival-promoting environment also rescues/protects leukemic cells from cytotoxic therapies, giving way to disease relapse. This review summarizes and discusses current knowledge about the intricate network of soluble and cell-bound signals regulating the life and death of CLL cells in different districts. At the same time, it seeks to hone in on which discrete molecular elements are best suited as targets for treating this still incurable disease.

Targeting the microenvironment in chronic lymphocytic leukemia offers novel therapeutic options.

AUDRITO, VALENTINA;VAISITTI, TIZIANA;SERRA, SARA;BOLOGNA, CINZIA;BRUSA, Davide;MALAVASI, Fabio;DEAGLIO, Silvia
2013

Abstract

Chronic lymphocytic leukemia (CLL) cells display features consistent with a defect in apoptosis and exhibit prolonged survival in vivo. Survival of these malignant cells is influenced by interactions with non-leukemic cells located in permissive niches in lymphoid organs. Leukemic cells subvert the normal architecture of the lymphoid organs, recruiting stromal cells, dendritic cells and T lymphocytes, all reported as playing active roles in the survival and proliferation of CLL. The same survival-promoting environment also rescues/protects leukemic cells from cytotoxic therapies, giving way to disease relapse. This review summarizes and discusses current knowledge about the intricate network of soluble and cell-bound signals regulating the life and death of CLL cells in different districts. At the same time, it seeks to hone in on which discrete molecular elements are best suited as targets for treating this still incurable disease.
328
27
35
http://ac.els-cdn.com/S0304383512004831/1-s2.0-S0304383512004831-main.pdf?_tid=f688cd6c-8023-11e2-985d-00000aab0f02&acdnat=1361890452_d8498d14452a283e7dde600f6b2ff709
Audrito V; Vaisitti T; Serra S; Bologna C; Brusa D; Malavasi F; Deaglio S.
File in questo prodotto:
File Dimensione Formato  
888291.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 409.68 kB
Formato Adobe PDF
409.68 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/118692
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact